Navigation Links
Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings
Date:3/13/2009

RESTON, Va., LONDON and GENEVA, March 13 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), a leader in education for healthcare professionals, and NAM, an award-winning community-based HIV information provider, have been named the official providers of online conference coverage and news from the 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2009) in Cape Town, South Africa, July 19-22, 2009, and the XVIII International AIDS Conference in Vienna, Austria, in 2010.

"We continue to be impressed with CCO's coverage of our annual meetings and are pleased to extend this relationship for the next 2 years," said Craig McClure, Executive Director of the IAS. "The addition of NAM's timely news reports will provide even greater coverage for the 5,000 delegates we expect in Cape Town, as well as those unable to attend, who will be well served by the editorial expertise and reach of both organizations."

Conference Coverage of the meeting will be the fourth official IAS program produced by CCO and will include summaries of important data presented in Cape Town as well as Expert Analyses of the impact of those data on the care of HIV-positive individuals around the world.

"We are honored to be selected again to deliver critical new information and educational resources from this important international scientific meeting to HIV treaters worldwide," said Jeffrey L. Drezner, MD, PhD, CCO's Chief Executive Officer and Founder. "By collaborating with NAM, we will be able to reach many more clinicians with even broader coverage of this esteemed conference."

NAM will provide daily coverage of the IAS 2009 meeting, including news reports and highlights bulletins in five languages, and both the NAM and CCO Web sites will be linked and integrated to bring full coverage to both organizations' free subscribers around the world.

"We're excited to work more closely with IAS and CCO this year and to continue to provide the important news from IAS 2009," said Caspar Thomson, NAM's Director. "Together, we will be able to provide extensive access to the proceedings to both our audiences."

About Clinical Care Options

Clinical Care Options, a leader in the development of innovative interactive medical education programs for healthcare professionals, creates and publishes original continuing medical education (CME) and information resources that translate the latest developments in science and medicine into treatment options. Utilizing internationally renowned, specialty-specific faculty and advisors, Clinical Care Options develops exceptional editorial content for its proprietary state-of-the-art technology and distributes it online via its own specialty portals in HIV, hepatitis, and oncology/hematology. In addition to its industry-leading Web-based programs, Clinical Care Options disseminates the latest in medical treatment through live meetings, including the national Annual Clinical Care Options HIV Symposium, and through print materials including books and monographs. For more information about the company and its programs, visit its Web site at www.clinicaloptions.com.

About NAM

NAM, a non-profit, non-governmental HIV information provider, produces and distributes accurate, up-to-date, and evidence-based resources, covering both the medical and social aspects of HIV, to people living with HIV and to those who work to treat, support, and care for them. NAM is a leading provider of HIV-related news coverage through its Web site www.aidsmap.com. NAM's work regularly receives awards and commendations including recognition from the British Medical Association every year since 1999. Some resources, including conference bulletins, are available in French, Spanish, Portuguese, and Russian. For more information, visit NAM's Web site at www.aidsmap.com.

About the IAS

The International AIDS Society (IAS) is the world's leading independent association of HIV/AIDS professionals. The IAS is the organizer of the IAS Conference on HIV Pathogenesis and Treatment and is custodian and lead organizer of the International AIDS Conference. The IAS has two main initiatives, the Industry Liaison Forum (ILF), focused on removing barriers to investment in research in resource-constrained nations, and eJIAS, a Web-based medical journal dedicated to the dissemination of HIV/AIDS research conducted in developing countries. For more information, visit the IAS Web site at www.ias2009.org.


'/>"/>
SOURCE Clinical Care Options
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Extended Release (ER) Phase 3 Clinical Data Presented at World Institute of Pain 5th Annual World Congress
2. Better health and prosperity in Europe via improved clinical research
3. BridgePoint Medical Completes First U.S. Clinical Case Using CrossBoss and Stingray Devices in CTO Angioplasty Procedure
4. Clinical Trial Fraud Exposed by Coast IRB
5. Alexza Reports 2008 Year-End Financial Results and Updates Clinical Pipeline Status
6. Swipe Card, See Image: OAD Orthopaedics Improves Clinical Workflow with OrthoFlow
7. M2S Announces New Addition to Electronic Image Management Offering for Clinical Trials
8. Commonly used beauty staple clinically proven to help treat eczema
9. NxStage Reports Sustained Reduction in Clinical Depressive Symptoms for Daily Home Hemodialysis Patients After One Year
10. Surface Logix Raises $20 Million in Financing and Starts Phase 2b Clinical Trial of SLx-4090 in Dyslipidemia and Diabetes
11. Alexza to Announce 2008 Financial Results and Update Its Clinical Pipeline on Tuesday, March 10, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: